ProfileGDS5678 / 1421048_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 18% 18% 17% 17% 17% 17% 18% 18% 18% 18% 17% 18% 18% 18% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4517318
GSM967853U87-EV human glioblastoma xenograft - Control 22.4271418
GSM967854U87-EV human glioblastoma xenograft - Control 32.4228617
GSM967855U87-EV human glioblastoma xenograft - Control 42.3764917
GSM967856U87-EV human glioblastoma xenograft - Control 52.3733217
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4809917
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4568418
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4109918
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4113418
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4162718
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4111417
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4014118
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.426618
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4193118